Wednesday, February 10, 2010, 11:24AM AEST - The Australian Stockmarket closes in 4 hours and 41 minutes.
To create a watchlist or portfolio of shares, Register

American Bio Medica Corp. (ABMC.PK)

4:24AM AEST: 0.10 USD   0.00 (0.00%)  
 MORE ON ABMC.PK 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 AMER BIO MEDICA (Other OTC:ABMC.PK) Delayed quote dataEdit
Last Trade:0.10 USD
Trade Time: 4:24AM AEST
Change: 0.00 (0.00%)
Prev Close:0.10
Open:0.10
Bid:N/A
Ask:N/A
1y Target Est:N/A
Day's Range:0.10 - 0.10
52wk Range:0.06 - 0.42
Volume:1,000
Avg Vol (3m):32,767.7
Market Cap:2.17M
P/E (ttm):N/A
EPS (ttm):-0.06
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add ABMC.PK to Portfolio   Download Data

 HEADLINES 
AMERICAN BIO MEDICA CORP Financials
EDGAR Online Financials (Sun, Feb 7)
AMERICAN BIO MEDICA CORP Files SEC form 10-K/A, Annual Report
EDGAR Online (Wed, Jan 20)
AMERICAN BIO MEDICA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Sat, Dec 19)
AMERICAN BIO MEDICA CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 14)
American Bio Medica Earnings Call scheduled for 11:00 am ET today
CCBN (Sat, Nov 14)
Bio Medica sales, earnings down in 3rd-Q
at bizjournals.com (Sat, Nov 14)
American Bio Medica Announces Third Quarter 2009 Results
Business Wire (Fri, Nov 13)
American Bio Medica Corporation 3rd Quarter 2009 Conference Call
Business Wire (Thu, Nov 12)
AMERICAN BIO MEDICA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
EDGAR Online (Sat, Aug 29)
AMERICAN BIO MEDICA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
EDGAR Online (Sat, Aug 29)
More Headlines for ABMC.PK...

 ANALYST 
EPS Est (next year) (Jan-70) :N/A
EPS Est (in 2 years) (Jan-70) :N/A
Avg Rec (current)*:N/A
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
American Bio Medica Corporation develops, manufactures, and sells immunoassay diagnostic test kits for the point of collection testing (POCT) for drugs of abuse in North America, Europe, the Asia/Pacific Rim, Africa, and South America.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices